The Institutional Biosafety Committee (IBC) reviews, approves and oversees research involving the use of recombinant or synthetic DNA/RNA and other biohazards. In accordance with the NIH Office of Science Policy update, Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, for all OMRF IBC meetings taking place on or after June 1, 2025, the IBC will post approved meeting minutes here. IBC meeting minutes will be posted immediately after approval and after all appropriate and allowable redactions are made.
Institutional Biosafety Committee Meeting Minutes
June 2025 – no meeting held
Contact the OMRF IBC
IBC Office
405-271-6670 ext. 32935
IBC@omrf.org
